CAXII Is a sero-diagnostic marker for lung cancer.
To develop sero-diagnostic markers for lung cancer, we generated monoclonal antibodies using pulmonary adenocarcinoma (AD)-derived A549 cells as antigens by employing the random immunization method. Hybridoma supernatants were immunohistochemically screened for antibodies with AMeX-fixed and paraffi...
Enregistré dans:
Auteurs principaux: | Makoto Kobayashi, Toshihide Matsumoto, Shinichiro Ryuge, Kengo Yanagita, Ryo Nagashio, Yoshitaka Kawakami, Naoki Goshima, Shi-Xu Jiang, Makoto Saegusa, Akira Iyoda, Yukitoshi Satoh, Noriyuki Masuda, Yuichi Sato |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f42a5fdb1ecd4432afc4c81d59c4e9e3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
par: Rui Han, et autres
Publié: (2021) -
Derrame pleural sero-fibrinoso en un lactante tuberculoso negativo
par: OYARCE ROJAS,PEDRO, et autres
Publié: (1949) -
Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
par: Emily J. Strong, et autres
Publié: (2018) -
Integrated human-animal sero-surveillance of Brucellosis in the pastoral Afar and Somali regions of Ethiopia.
par: Rea Tschopp, et autres
Publié: (2021) -
Stabilizing Genetically Unstable Simple Sequence Repeats in the <named-content content-type="genus-species">Campylobacter jejuni</named-content> Genome by Multiplex Genome Editing: a Reliable Approach for Delineating Multiple Phase-Variable Genes
par: Shouji Yamamoto, et autres
Publié: (2021)